Tevogen Bio Holdings Inc. (TVGN)

Tevogen Bio Holdings Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	2.33	1.05	5.48	7.12
Cash & Short-Term Investments	2.33	1.05	5.48	7.12
Cash Growth	-10.59%	-80.81%	-22.96%	-
Prepaid Expenses	1.04	0.67	0.35	0.05
Total Current Assets	3.53	1.72	5.84	7.17
Property, Plant & Equipment	0.63	0.93	1.31	0.14
Long-Term Deferred Charges	-	2.58	-	-
Other Long-Term Assets	0.13	0.27	0.59	0.34
Total Assets	4.29	5.51	7.74	7.66
Accounts Payable	5.84	3.42	0.87	0.38
Accrued Expenses	1.59	0.09	0.58	0.24
Current Portion of Long-Term Debt	-	80.71	-	-
Current Portion of Leases	0.26	0.25	0.28	-
Other Current Liabilities	0.06	1	0.24	0.05
Total Current Liabilities	10.42	85.48	1.96	0.67
Long-Term Debt	-	14.22	39.3	23.48
Long-Term Leases	0.04	0.23	0.43	-
Total Liabilities	10.48	99.93	41.69	24.15
Common Stock	0.02	0.06	0.06	0.06
Additional Paid-In Capital	90.93	5.17	5.17	0.59
Retained Earnings	-103.94	-99.66	-39.18	-17.14
Shareholders' Equity	-6.19	-94.43	-33.95	-16.49
Total Liabilities & Equity	4.29	5.51	7.74	7.66
Total Debt	2.96	95.42	40.01	23.48
Net Cash (Debt)	-0.63	-94.37	-34.52	-16.36
Net Cash Per Share	-0.01	-3.81	-1.37	-0.65
Filing Date Shares Outstanding	175.05	164.61	24.75	25.08
Total Common Shares Outstanding	170.77	24.75	24.75	25.08
Working Capital	-6.89	-83.76	3.88	6.51
Book Value Per Share	-0.08	-3.81	-1.37	-0.66
Tangible Book Value	-12.99	-94.43	-33.95	-16.49
Tangible Book Value Per Share	-0.08	-3.81	-1.37	-0.66
Machinery	-	0.46	0.46	0.15
Leasehold Improvements	-	0.26	0.26	-

Source: S&P Capital IQ. Standard template. Financial Sources.